Key result
MRgHIFU renal sympathetic denervation significantly reduced the cross-sectional area of renal nerve bundles by approximately 25% (p=0.04) compared to the untreated contralateral side in a porcine model.
Why the study?
Does MRgHIFU-mediated renal sympathetic denervation reduce kidney norepinephrine levels and nerve bundle area in a normotensive porcine model?
Does MRgHIFU-mediated renal sympathetic denervation reduce kidney norepinephrine levels and nerve bundle area in a normotensive porcine model?
Non-invasive renal sympathetic denervation using MRgHIFU is feasible and safe in a porcine model, resulting in reduced renal nerve area and a trend toward lower kidney norepinephrine levels.
Answers are grounded in this paper and cite their sources.
Feasibility shown for MRgHIFU renal denervation in pigs; leaves open translation to human hypertension therapy.
BACKGROUND: Initial catheter-based renal sympathetic denervation (RSD) studies demonstrated promising results in showing a significant reduction of blood pressure, while recent data were less successful. As an alternative approach, the objective of this study was to evaluate the feasibility of using magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) to perform RSD in a porcine model. METHODS: An intravascular fiber optic temperature probe was used to confirm energy delivery during MRgHIFU. This technique was evaluated both in a vascular phantom and in a normotensive pig model. Five animals underwent unilateral RSD using MRgHIFU, and both safety and efficacy were assessed. MRI was used to evaluate the acoustic window, target sonications, monitor the near-field treatment region using MR thermometry imaging, and assess the status of tissues post-procedure. An intravascular fiber optic temperature probe verified energy delivery. Animals were sacrificed 6 to 9 days post-treatment, and pathological analysis was performed. The norepinephrine present in the kidney medulla was assessed post-mortem. RESULTS: All animals tolerated the procedure well with no observed complications. The fiber optic temperature probe placed in the target renal artery confirmed energy delivery during MRgHIFU, measuring larger temperature rises when the MRgHIFU beam location was focused closer to the tip of the probe. Following ablation, a significant reduction (p = 0.04) of cross-sectional area of nerve bundles between the treated and untreated renal arteries was observed in all of the animals with treated nerves presenting increased cellular infiltrate and fibrosis. A reduction of norepinephrine (p = 0.14) in the kidney medulla tissue was also observed. There was no indication of tissue damage in arterial walls. CONCLUSIONS: Performing renal denervation non-invasively with MRgHIFU was shown to be both safe and effective as determined by norepinephrine levels in a porcine model. This approach may be a promising alternative to catheter-based strategies.
No takes yet. Share an insight, caveat, or question.
Koopmann et al. (2016) studied Renal sympathetic denervation (normotensive model) (n=5). Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) vs. Contralateral untreated renal artery was evaluated on Cross-sectional area of nerve bundles (ratio 0.74, p=0.04). MRgHIFU renal sympathetic denervation significantly reduced the cross-sectional area of renal nerve bundles by approximately 25% (p=0.04) compared to the untreated contralateral side in a porcine model.
Synapse has enriched 10 related papers. Consider them for comparative context: